BerandaCORT • NASDAQ
add
Corcept Therapeutics Inc
$74,33
Setelah Jam Perdagangan Normal:(0,00%)0,00
$74,33
Tutup: 26 Jun, 16.01.31 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$73,99
Rentang hari
$72,48 - $74,43
Rentang tahun
$29,44 - $117,33
Kapitalisasi pasar
7,89Â M USD
Volume Rata-Rata
1,28Â jt
Rasio P/E
63,88
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 157,21Â jt | 7,09% |
Biaya operasional | 151,40Â jt | 31,91% |
Laba bersih | 20,55Â jt | -25,99% |
Margin laba bersih | 13,07 | -30,88% |
Penghasilan per saham | 0,17 | -32,00% |
EBITDA | 3,70Â jt | -87,71% |
Tarif pajak efektif | -113,63% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 322,76Â jt | -21,42% |
Total aset | 846,46Â jt | 29,05% |
Total liabilitas | 163,17Â jt | 50,98% |
Total ekuitas | 683,28 jt | — |
Saham yang beredar | 106,04 jt | — |
Harga terhadap nilai buku | 11,47 | — |
Tingkat pengembalian aset | 1,01% | — |
Tingkat pengembalian modal | 1,24% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 20,55Â jt | -25,99% |
Kas dari operasi | 5,13Â jt | -78,41% |
Kas dari investasi | -3,17Â jt | 64,82% |
Kas dari pembiayaan | -39,80Â jt | -7.230,20% |
Perubahan kas bersih | -37,85Â jt | -366,54% |
Arus kas bebas | -1,01Â jt | -104,44% |
Tentang
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
Didirikan
13 Mei 1998
Kantor pusat
Situs
Karyawan
500
